Carpal Tunnel SyndromePhase 4NCT06349824
Dextrose, Steroid, PRP: Choosing the Right Injection for CRS Relief; a RCT
A Phase 4 study testing injection Dextrose water and USG machine in people with Carpal Tunnel Syndrome, run by Sheikh Zayed Medical College at 1 site in Pakistan.
Trial summary
USG guided injections to relieve carpal tunnel syndrome with dextrose water or steroid or PRP Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Carpal Tunnel Syndrome
- What is being tested?
- injection Dextrose water and USG machine
- Type of treatment
- Injection or infusion, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 sitePakistan
- Study dates
- 10 Oct 2023to 30 Mar 2024
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- NA
Who cannot join
- Na
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Sheikh Zayed Medical College
Rahim Yar Khan, Punjab Province, 64200
About this study
Official title: Dextrose, Steroid, PRP: Choosing the Right Injection for Long Term CRS Relief; a RCT
USG guided injections to relieve carpal tunnel syndrome with dextrose water or steroid or PRP
- Conditions
- Carpal Tunnel Syndrome
- Being tested
- injection Dextrose water, USG machine
- Medical subject headings
- Carpal Tunnel Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
injection Dextrose waterDrug
Also called PRP
dextrose will be injected around median nerve in wrist
USG machineDevice
usg guided nerve hydrdissection
| Study group | Role | What they receive |
|---|---|---|
| Dextrose | Experimental | Not described Receives: Device: USG machine |
| Steroid | Experimental | Not described Receives: Drug: injection Dextrose water; Device: USG machine |
| PRP | Experimental | Not described Receives: Drug: injection Dextrose water; Device: USG machine |
What is being measured
The primary outcome is the main question the study is designed to answer.
VAS
visual pain score at different intervals
Measured: five to six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Apr 2024
- Study start10 Oct 2023
- Primary completion30 Mar 2024
- Study completion30 Mar 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Carpal Tunnel SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sheikh Zayed Medical College
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Sairah Sadaf, Sheikh Zayed Medical College
- Investigators
- sairah sadaf, Principal investigator, sheikh zayed medical college rhaim yar khan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06349824
- Sponsor's protocol ID
- 004AEstb/EC/01/2022
- Status last verified
- Mar 2024
- First submitted
- 31 Mar 2024
- Last updated
- 5 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dextrose, Steroid, PRP: Choosing the Right Injection for Long Term CRS Relief; a RCT
- ClinicalTrials.gov ID
- NCT06349824
- Acronym / sponsor ID
- 004AEstb/EC/01/2022
- Conditions
- Carpal Tunnel Syndrome
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Sheikh Zayed Medical CollegeOther government
- Study start
- 10 Oct 2023 (actual)
- Primary completion
- 30 Mar 2024 (actual)
- Study completion
- 30 Mar 2024 (actual)
- First posted
- 5 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
USG guided injections to relieve carpal tunnel syndrome with dextrose water or steroid or PRP
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Dextrose | Experimental | Device: USG machine |
| Steroid | Experimental | Drug: injection Dextrose water, Device: USG machine |
| PRP | Experimental | Drug: injection Dextrose water, Device: USG machine |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- NA
Key exclusion criteria (1 listed)
- Na
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| injection Dextrose waterAlso: PRPdextrose will be injected around median nerve in wrist | Drug | PRP, Steroid |
| USG machineusg guided nerve hydrdissection | Device | Dextrose, PRP, Steroid |
Primary outcome
VAS
Time frame: five to six months
visual pain score at different intervals
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Apr 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Carpal Tunnel Syndrome
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
Recruiting
Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Peripheral Neuropathies
Recruiting
Effects of Repetitive Peripheral Magnetic Stimulation(rPMS) on CTS(Carpal Tunnel Syndrome)
Carpal Tunnel Syndrome (CTS)
Recruiting
Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS) Post-burn
Not yet recruiting
Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release
Carpal Tunnel Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
sairah sadaf principal investigator
sheikh zayed medical college rhaim yar khan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing injection Dextrose water and USG machine in people with Carpal Tunnel Syndrome, run by Sheikh Zayed Medical College at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
VAS (time frame: five to six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2024.